ECE2024 Eposter Presentations Reproductive and Developmental Endocrinology (78 abstracts)
1Royal Free Hospital, United Kingdom; 2University of Birmingham Medical School, United Kingdom; 3South Tyneside NHS Foundation Trust, United Kingdom; 4Yeditepe university, Turkey; 5Clinic NeoLab კლინიკა ნეოლაბი, Tbilisi, Georgia; 6Institute of Applied Health Research, United Kingdom; 7Queen Elizabeth Hospital Birmingham, United Kingdom
Objective: To explore whether assessments recommended by the International PCOS guidelines during the initial consultation for PCOS varied by ethnicity.
Methods: This retrospective multi-centre study was conducted from June 2023 to January 2024. All women aged >18 who attended their first consultation in a dedicated PCOS clinic from January 2020 to December 2023 in the UK (n=359), Turkey (n=239), Greece (n=92), and Georgia (n=10) were included. Those undergoing follow-up or without PCOS were excluded. Data was collected on sociodemographic variables including ethnicity, and assessments, including diagnosis based on guidelines, cardiometabolic risk, dermatological assessment, emotional well-being, long-term risk education, lifestyle management, and reproductive screening. Descriptive statistics were analysed using SPSS 28.0.
Results: 75.5% were White, 4.3% were Asian, 10.3% were Black, mixed, or other groups, and 9.7% preferred not to disclose their ethnicity. The most common reasons for referral were irregular periods (65.7%), excess hair growth (61.1%), and acne (38.9%). Irregular periods, excess hair growth and acne were all higher in the White group (prevalence rates, 67.9%, 63.6% and 45.7%, respectively) compared to the Asian group (53.3%, 53.3%, and 13.3%, respectively) and the group of Black, mixed or other ethnic background (66.7%, 54.2%, 15.3%; respectively). The most common co-morbidities were anxiety (9.7%), hypothyroidism (9.0%), and depression (6.7%). The prevalence of anxiety was similar across White (9.81%), Asian (10.0%), and Black, mixed and other (6.9%) groups. Depression was higher in the Asian group (13.3%) compared to White (5.5%) and Black, mixed or other (5.6%) groups. Dermatological concerns and reproductive screening were more commonly assessed in the White group (93.8% and 91.3%, respectively) compared to the Asian and Black, mixed or other groups. Screening for emotional well-being was particularly lower in the Asian (30.0%) and Black, mixed or other groups (22.2%), compared to the White group (70.0%). Similar trends were seen with long-term risk education, which was higher in the White group (56.1%) compared to Asian (23.3%) and Black, mixed or other (9.7%) groups.
Conclusion: There is a significant gap in the parameters assessed according to ethnicity, as recommended by international PCOS guidelines. Specifically, emotional well-being screening and long-term risk education are lower in minority ethnic groups, highlighting the need for a standardised approach to the assessment of PCOS to provide equal patient care.